Michelson Medical Research Foundation’s iShares MSCI South Korea ETF EWY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.07M Hold
20,155
3.76% 12
2026
Q1
$2.48M Hold
20,155
2.52% 15
2025
Q4
$1.96M Hold
20,155
1.96% 15
2025
Q3
$1.61M Hold
20,155
1.4% 18
2025
Q2
$1.45M Hold
20,155
1.39% 19
2025
Q1
$1.09M Hold
20,155
0.91% 23
2024
Q4
$1.03M Hold
20,155
0.86% 26
2024
Q3
$1.29M Hold
20,155
0.91% 27
2024
Q2
$1.33M Hold
20,155
1.15% 23
2024
Q1
$1.35M Hold
20,155
0.82% 25
2023
Q4
$1.32M Hold
20,155
0.87% 24
2023
Q3
$1.19M Buy
+20,155
New +$1.28M 0.8% 26

Other funds holding EWY

Michelson Medical Research Foundation's EWY Position: Q2 2026 in Review

Michelson Medical Research Foundation held its iShares MSCI South Korea ETF (EWY) position steady in Q2 2026 at 20,155 shares worth $4.07M. The position accounts for 3.76% of the portfolio, ranked #12.

Michelson Medical Research Foundation first reported a position in EWY in Q3 2023 and has held it in 12 quarters since. 599 funds tracked by Wall St. Rank hold EWY as of Q2 2026.

  • Michelson Medical Research Foundation held 20,155 shares of iShares MSCI South Korea ETF worth $4.07M as of Q2 2026.
  • Michelson Medical Research Foundation left its iShares MSCI South Korea ETF share count unchanged in Q2 2026.
  • iShares MSCI South Korea ETF made up 3.76% of Michelson Medical Research Foundation's portfolio in Q2 2026, its #12 holding.
  • Michelson Medical Research Foundation first reported a position in iShares MSCI South Korea ETF in Q3 2023 and has held it in 12 quarters since.
  • 599 funds tracked by Wall St. Rank held iShares MSCI South Korea ETF as of Q2 2026.

Based on Michelson Medical Research Foundation's 13F filing for Q2 2026, filed 14 Aug 2026.